Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuraxis (NRXS) Net Income towards Common Stockholders (2022 - 2025)

Neuraxis (NRXS) has disclosed Net Income towards Common Stockholders for 4 consecutive years, with -$1.9 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders fell 17.91% to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8.6 million through Dec 2025, down 1.92% year-over-year, with the annual reading at -$8.6 million for FY2025, 1.92% down from the prior year.
  • Net Income towards Common Stockholders hit -$1.9 million in Q4 2025 for Neuraxis, up from -$2.3 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$206423.0 in Q4 2022 to a low of -$5.3 million in Q4 2023.
  • Historically, Net Income towards Common Stockholders has averaged -$2.3 million across 4 years, with a median of -$2.1 million in 2024.
  • Biggest five-year swings in Net Income towards Common Stockholders: tumbled 2473.99% in 2023 and later surged 69.62% in 2024.
  • Year by year, Net Income towards Common Stockholders stood at -$206423.0 in 2022, then crashed by 2473.99% to -$5.3 million in 2023, then soared by 69.62% to -$1.6 million in 2024, then dropped by 17.91% to -$1.9 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for NRXS at -$1.9 million in Q4 2025, -$2.3 million in Q3 2025, and -$1.9 million in Q2 2025.